Posttransplant Malignancy
- PMID: 30471741
- DOI: 10.1016/j.suc.2018.09.004
Posttransplant Malignancy
Abstract
Posttransplant malignancy is a leading cause of death after solid organ transplantation (SOT). Recipients of SOT are at significantly higher risk of multiple cancers compared with the general population, most notably nonmelanoma skin cancer and posttransplant lymphoproliferative disorders. Risk factors for posttransplant malignancy include history of malignancy, immunosuppression, oncogenic viral infections, sun exposure, and disease-specific associations. Early detection and treatment of malignancies can improve survival.
Keywords: Cancer; Cancer screening; Malignancy; Solid organ transplant; Transplantation.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.Radiographics. 2016 Sep-Oct;36(5):1390-407. doi: 10.1148/rg.2016150175. Radiographics. 2016. PMID: 27618321 Review.
-
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.Am J Transplant. 2017 Aug;17(8):1974-1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10. Am J Transplant. 2017. PMID: 28394486 Review.
-
Posttransplant lymphoproliferative diseases.Pediatr Clin North Am. 2010 Apr;57(2):481-503, table of contents. doi: 10.1016/j.pcl.2010.01.011. Pediatr Clin North Am. 2010. PMID: 20371048 Review.
-
Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.Clin Transplant. 1996 Jun;10(3):248-55. Clin Transplant. 1996. PMID: 8826661
-
Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.Mayo Clin Proc. 2018 Sep;93(9):1236-1246. doi: 10.1016/j.mayocp.2018.04.025. Epub 2018 Jul 29. Mayo Clin Proc. 2018. PMID: 30064826
Cited by
-
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?Int J Mol Sci. 2019 May 3;20(9):2194. doi: 10.3390/ijms20092194. Int J Mol Sci. 2019. PMID: 31058839 Free PMC article. Review.
-
Crocin Promotes Apoptosis in Human EBV-Transformed B-Lymphocyte via Intrinsic Pathway.Mediterr J Hematol Infect Dis. 2021 Jul 1;13(1):e2021049. doi: 10.4084/MJHID.2021.049. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34276918 Free PMC article.
-
Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota.Integr Cancer Ther. 2019 Jan-Dec;18:1534735419846379. doi: 10.1177/1534735419846379. Integr Cancer Ther. 2019. PMID: 31014119 Free PMC article. Review.
-
Oncological and Functional Outcomes of Robot-Assisted Radical Prostatectomy in Kidney Transplant Recipients.JSLS. 2021 Jul-Sep;25(3):e2021.00045. doi: 10.4293/JSLS.2021.00045. JSLS. 2021. PMID: 34552318 Free PMC article.
-
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.Dermatol Ther (Heidelb). 2023 Apr;13(4):867-889. doi: 10.1007/s13555-023-00905-3. Epub 2023 Mar 16. Dermatol Ther (Heidelb). 2023. PMID: 36929121 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical